We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Research Institutes Partner to Develop a Global Center for Transformative Nanomedicine

By LabMedica International staff writers
Posted on 25 Oct 2015
Print article
Two internationally renowned biomedical research institutions have agreed to collaborate in the establishment of a virtual center to boost development of nanotechnological techniques for diagnosis and treatment of disease.

The Hebrew University of Jerusalem (Israel) and the Cleveland Clinic (OH, USA) announced a five-year commitment to raise at least 15 million USD as initial funding to establish the virtual Center for Transformative Nanomedicine. This center will sponsor interdisciplinary research at the Hebrew University in combination with the Cleveland Clinic’s Department of Biomedical Engineering with the goal of developing nanotechniques that will facilitate therapy and new ways of diagnosing diseases.

Research efforts will encompass a wide range of illnesses including cardiovascular diseases, neurological diseases, and cancer. Investigators involved in the program will endeavor to develop nanomethods for drug transport that will allow delivery of large doses of drugs to be released at a specific site and only to that site, causing fewer side effects than traditional treatments. In addition, they plan to develop inexpensive nanoscale devices to facilitate therapy and diagnosis.

“Our two institutions will leverage resources and begin to combine our scientific knowledge,” said Dr. Menahem Ben-Sasson, president of The Hebrew University of Jerusalem. “These powerful interactions will expedite better medical treatments, more rapid, cost-effective diagnostics, and improved healthcare delivery for people the world over.”

“We are honored to join with Hebrew University to advance the emerging field of nanotechnology,” said Dr. Toby Cosgrove, president and CEO of the Cleveland Clinic. “The new Center for Transformative Nanomedicine will ensure development of novel therapeutics to improve longevity, enhance patient well-being, make medical care more cost-effective, and provide dynamic solutions to global health concerns.”

The initial development stage will be directed by Dr. D. Geoffrey Vince, of the Cleveland Clinic and Dr. Simon Benita of the Hebrew University of Jerusalem.

Related Links:

The Hebrew University of Jerusalem
Cleveland Clinic


Flocked Swab
HydraFlock and PurFlock Ultra
New
Gold Supplier
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
New
Portable Coagulation Monitor
VCM
New
Gold Supplier
CLIA Analyzer
VIRCLIA

Print article

Channels

Clinical Chem.

view channel
Image: Electrochemical cells etched by laser on wooden tongue depressor measure glucose and nitrite in saliva (Photo courtesy of Analytical Chemistry)

Biosensor-Fabricated Wooden Tongue Depressor Measures Glucose and Nitrite in Saliva

Physicians often use tongue depressors to examine a patient's mouth and throat. However, it is hard to imagine that this simple wooden tool could actively assess a patient's health. This idea has led to... Read more

Hematology

view channel
Image: The Atellica HEMA 570 and 580 hematology analyzers remove workflow barriers (Photo courtesy of Siemens)

Next-Gen Hematology Analyzers Eliminate Workflow Roadblocks and Achieve Fast Throughput

Hematology testing is a critical aspect of patient care, utilized to establish a patient's health baseline, track treatment progress, or guide timely modifications to care. However, increasing constraints... Read more

Immunology

view channel
Image: Newly observed anti-FSP antibodies have also been found to predict immune-related adverse events (Photo courtesy of Calviri)

First Blood-Based Biomarkers Test to Predict Treatment Response in Cancer Patients

Every year worldwide, lung cancer afflicts over two million individuals and almost the same number of people succumb to the disease. This malignancy leads the charts in cancer-related mortalities, with... Read more

Microbiology

view channel
Image: The rapid MTB strip test for tuberculosis can identify TB patients within two hours (Photo courtesy of Chulalongkorn University)

Rapid MTB Strip Test Detects Tuberculosis in Less Than an Hour without Special Tools

Tuberculosis (TB), a highly infectious disease, continues to pose significant challenges to public health worldwide. TB is caused by a bacterium known as "Mycobacterium tuberculosis," spreading through... Read more

Pathology

view channel
Image: The UNIQO 160 (CE-IVDR) advances diagnostic analysis for autoimmune diseases (Photo courtesy of EUROIMMUN)

Novel Automated IIFT System Enables Cutting-Edge Diagnostic Analysis

A newly-launched automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics offers an all-in-one solution to enhance the efficiency of the complete IIFT process, comprising... Read more

Technology

view channel
Electronic biosensor uses DNA aptamers for detecting biomarkers in whole blood samples (Photo courtesy of Freepik)

Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents

The absence of robust, reliable, and user-friendly bioanalytical tools for early and timely diagnosis of cardiovascular diseases, particularly sudden cardiac arrest, leads to preventable deaths and imposes... Read more

Industry

view channel
Image: The global HbA1c testing devices market is expected to reach USD 2.56 billion in 2027 (Photo courtesy of Freepik)

Global Hemoglobin A1c Testing Devices Market Driven by Rising Prevalence of Diabetes

Hemoglobin A1c (HbA1c), or glycated hemoglobin, refers to hemoglobin with glucose attached. HbA1c testing devices are used for blood tests that determine average blood glucose, or blood sugar levels.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.